Skip to content

Clinical trials

Completed Endometrial Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Status: Completed Clear all

510 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200013
200115
200213
200310
200417
200514
200612
200722
200821
200911
201015
201121
201225
201318
201426
201511
201633
201728
201830
201933
202025
202118
202212
202314
202417
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed510

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)34
M.D. Anderson Cancer Center17
Memorial Sloan Kettering Cancer Center16
Gynecologic Oncology Group11
European Organisation for Research and Treatment of Cancer - EORTC9
UNC Lineberger Comprehensive Cancer Center9
Ohio State University Comprehensive Cancer Center8
Case Comprehensive Cancer Center7
Masonic Cancer Center, University of Minnesota6
Merck Sharp & Dohme LLC6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms510
Ovarian Neoplasms136
Uterine Cervical Neoplasms135
Breast Neoplasms87
Neoplasms64
Fallopian Tube Neoplasms54
Prostatic Neoplasms47
Carcinoma, Ovarian Epithelial41
Carcinoma, Non-Small-Cell Lung40
Vaginal Neoplasms40

Trials

Showing 1 to 25 of 510. Each trial links to its page on Pharma Observatory.

410 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.